Real-time feedback of patient-reported outcomes feasible for patients and clinicians!
The Myeloma 1000 Biobank now has samples from over 400 patients!
FRAIL-M, a trial using MRDR infrastructure, has commenced recruitment.
Dr Jessie Zhao's presentation on treatment patterns in myeloma was awarded a Snowdome travel grant.
The MRDR was well represented at the Blood 2019 conference in Perth in October.
The MRDR had a busy and productive meeting at the IMW in Boston, USA.
An MRDR paper on renal impairment in myeloma by Prof Joy Ho was recently published.